학술논문

Medication delivery factors and adjuvant endocrine therapy adherence in breast cancer
Document Type
Academic Journal
Source
Breast Cancer Research and Treatment. January, 2023, Vol. 197 Issue 1, p223, 11 p.
Subject
Cancer -- Adjuvant treatment
Mail-order industry -- Usage
Patient compliance -- Analysis -- Usage -- Research
Comorbidity -- Care and treatment -- Research
Drugstores -- Usage
Drugs -- Research -- Usage
Pharmacy -- Usage
Breast cancer -- Research -- Care and treatment
Language
English
ISSN
0167-6806
Abstract
Purpose Over 50% of breast cancer patients prescribed a 5-year course of daily oral adjuvant endocrine therapy (ET) are nonadherent. We investigated the role of costs and cancer medication delivery mode and other medication delivery factors on adherence. Methods We conducted a retrospective cohort study of commercially insured and Medicare advantage patients with newly diagnosed breast cancer in 2007-2015 who initiated ET. We examined the association between 12-month ET adherence (proportion of days covered by fills [greater than or equal to] 0.80) and ET copayments, 90-day prescription refill use, mail order pharmacy use, number of pharmacies, and synchronization of medications. We used regression models to estimate nonadherence risk ratios adjusted for demographics (age, income, race, urbanicity), comorbidities, total medications, primary cancer treatments, and generic AI availability. Sensitivity analyses were conducted using alternative specifications for independent variables. Results Mail order users had higher adherence in both commercial and Medicare-insured cohorts. Commercially insured patients who used mail order were more likely to be adherent if they had low copayments (< $5) and 90-day prescription refills. For commercially insured patients who used local pharmacies, use of one pharmacy and better synchronized refills were also associated with adherence. Among Medicare patients who used mail order pharmacies, only low copayments were associated with adherence, while among Medicare patients using local pharmacies both low copayments and 90-day prescriptions were associated with ET adherence. Conclusion Out-of-pocket costs, medication delivery mode, and other pharmacy-related medication delivery factors are associated with adherence to breast cancer ET. Future work should investigate whether interventions aimed at streamlining medication delivery could improve adherence for breast cancer patients.
Author(s): Joan M. Neuner [sup.1] [sup.2], Nicole Fergestrom [sup.2], Liliana E. Pezzin [sup.3], Purushottam W. Laud [sup.2] [sup.4], Kathryn J. Ruddy [sup.5], Aaron N. Winn [sup.6] Author Affiliations: (1) grid.30760.32, [...]